Drug-Induced Autoimmune-Like Hepatitis: Diagnostic and Therapeutic Challenges 

Nov 18 2024
Convention Center: Room 25 B
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

Raul Andrade, MD, PhD, FAASLD
Discussion Leader

Raul Andrade, MD, PhD, FAASLD

IBIMA-Plataforma BIONAND, UMA, CIBERehd
Nelia Hernandez, MD
Discussion Leader

Nelia Hernandez, MD

Clinicas Hospital, Faculty of Medicine

Description

Experts discuss the drugs that commonly mimic autoimmune hepatitis and the challenges associated with diagnosis and management of this disorder. 

Journey Maps

Objectives

  • Identify which drugs commonly cause drug-induced autoimmune-like hepatitis.
  • Describe how the management of drug-induced autoimmune-like hepatitis differs from that of autoimmune hepatitis.